ALZN Alzamend Neuro Inc
Company Analysis
Latest News
🟢 Alzamend Neuro is trading 5.2% up today as growth stocks rally on softer inflation data
Alzamend Neuro is trading at $1.22, up 5.2% today, as the stock rebounds from recent selling pressure driven by geopolitical tensions and sector-wide...
🔴 Alzamend Neuro is trading 5.7% down today, extending losses amid biotech sector pressure and geopolitical tensions
Alzamend Neuro is trading 5.7% down at $1.09 in pre-market, extending weakness from the prior session amid broader biotech-sector pressure. • Shares fell...
🔴 Alzamend Neuro is trading 5.9% down today amid biotech weakness and geopolitical tensions
Alzamend Neuro is trading 5.9% down today at $1.12 amid broader biotech sector weakness and risk-off sentiment tied to escalating U.S.–Iran geopolitical...
🔴 Alzamend Neuro Drops 5.2% Amid Reports of Significant Net Loss
• Alzamend Neuro is trading 5.2% down today at $1.09. • The company recently reported a net loss of $2.7 million, with an earnings per share (EPS) of $(1.28),...
🔴 ALZN is trading 5.85% down today on continued weakness following Alzheimer’s trial data disclosures
ALZN is trading at $1.08 (5.85% down) in after-hours, extending recent weakness following a sharp drop tied to new Alzheimer’s trial data disclosures. •...
🔴 ALZN trading 15% down today after company announced presentation of new trial data at AAIC 2026
• ALZN is trading 15% down at $0.99 today. • The movement follows Alzheon's announcement on July 6, 2026, detailing presentations of new clinical, imaging, and...
🟢 ALZN is trading 5.2% up today as it extends a recent rebound
ALZN is trading 5.2% higher at $1.22 in pre-market, extending a rebound after closing at $1.16 on July 03, 2026. • The move appears to be a continuation of a...